Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 305 citing articles:

SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Evgeni Gusev, Alexey Sarapultsev, Л. В. Соломатина, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1716-1716
Open Access | Times Cited: 224
Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective
Yong-Sheng Zhang, Xinjie Liang, Xuefei Bao, et al.
European Journal of Medicinal Chemistry (2022) Vol. 235, pp. 114291-114291
Closed Access | Times Cited: 174
Role of toll‐like receptors in modulation of cytokine storm signaling in SARS‐CoV‐2‐induced COVID‐19
Moumita Manik, Rakesh Kumar Singh
Journal of Medical Virology (2021) Vol. 94, Iss. 3, pp. 869-877
Open Access | Times Cited: 139
COVID-19 and Myositis: What We Know So Far
Ahmad Saud, R Naveen, Rohit Aggarwal, et al.
Current Rheumatology Reports (2021) Vol. 23, Iss. 8
Open Access | Times Cited: 136
Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?
Theoharis C. Theoharides
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1850-1861
Open Access | Times Cited: 128
SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice
Fabrícia Lima Fontes-Dantas, Gabriel Gripp Fernandes, Elisa Gouvea Gutman, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112189-112189
Open Access | Times Cited: 111
Understanding the Role of SARS-CoV-2 ORF3a in Viral Pathogenesis and COVID-19
Jiantao Zhang, Amara Ejikemeuwa, Volodymyr Gerzanich, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 109
The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets
Alhamdu Adamu, Shuo Li, Fankai Gao, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 101
Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID
Theoharis C. Theoharides, Duraisamy Kempuraj
Cells (2023) Vol. 12, Iss. 5, pp. 688-688
Open Access | Times Cited: 55
PAMPs and DAMPs in Sepsis: A Review of Their Molecular Features and Potential Clinical Implications
Sara Cicchinelli, Giulia Pignataro, Stefania Gemma, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 962-962
Open Access | Times Cited: 29
Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus
Inés Valencia, Jairo Lumpuy‐Castillo, Giselle Santos Magalhães, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 22
Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
Masoumeh Farahani, Zahra Niknam, Leila Mohammadi Amirabad, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112420-112420
Open Access | Times Cited: 103
Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines
Rossella Sartorius, Maria Trovato, Roberta Manco, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 95
The Role of Epithelial Damage in the Pulmonary Immune Response
Rachel A. Burgoyne, Andrew J. Fisher, Lee A. Borthwick
Cells (2021) Vol. 10, Iss. 10, pp. 2763-2763
Open Access | Times Cited: 92
Immunogenomics guided design of immunomodulatory multi-epitope subunit vaccine against the SARS-CoV-2 new variants, and its validation through in silico cloning and immune simulation
Abbas Khan, Shahzeb Khan, Shoaib Saleem, et al.
Computers in Biology and Medicine (2021) Vol. 133, pp. 104420-104420
Open Access | Times Cited: 73
Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies
Mariya Farooq, Maria Batool, Moon Suk Kim, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 73
Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments
Zhimei Liu, Minghui Yang, Kun Yu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 49
Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions
Yujie Jiang, Tingmei Zhao, Xueyan Zhou, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 48
Toll-like Receptor 4 in COVID-19: Friend Or foe?
Suprabhat Mukherjee
Future Virology (2022) Vol. 17, Iss. 7, pp. 415-417
Open Access | Times Cited: 45
Understanding the Pharmacology of COVID-19 mRNA Vaccines: Playing Dice with the Spike?
Marco Cosentino, Franca Marino
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10881-10881
Open Access | Times Cited: 42
Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms
Brent Brown, Vanshika Ojha, Ingo Fricke, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 37
TLRs: Innate Immune Sentries against SARS-CoV-2 Infection
Stefania Mantovani, Barbara Oliviero, Stefania Varchetta, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8065-8065
Open Access | Times Cited: 35
Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection
Peiran Chen, Mandi Wu, Yaqing He, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 34
COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events
Girolamo Giannotta, Antonio Murrone, Nicola Giannotta
Vaccines (2023) Vol. 11, Iss. 4, pp. 747-747
Open Access | Times Cited: 31
Beyond Acute COVID-19: A Review of Long-term Cardiovascular Outcomes
Parinaz Parhizgar, Nima Yazdankhah, Anna Rzepka, et al.
Canadian Journal of Cardiology (2023) Vol. 39, Iss. 6, pp. 726-740
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top